David has dedicated his career to improving patient outcomes in oncology, ensuring that people across Ireland have access to the latest advancements in cancer treatment. With over 20 years of experience in the pharmaceutical and biotech industry, he has led teams across multiple therapeutic areas and functions such as market access, sales and marketing, always keeping patients at the heart of his work.
At MSD Ireland, David leads the oncology division, working closely with healthcare professionals, patient groups, and key stakeholders to bring innovative therapies to those who need them most. He is passionate about driving collaboration across the healthcare ecosystem, ensuring that MSD Ireland continues to play a leading role in advancing cancer care in Ireland.
Committed to making a real impact, David is actively involved in shaping oncology strategy, policy, and access initiatives. He believes in fostering a culture of innovation, resilience, and partnership, helping to bring the next generation of breakthrough treatments to patients in Ireland and beyond.
Currently acting as Interim Leader of Human Health for MSD Ireland, David is focused on driving the organisation’s broader mission, ensuring patients across multiple therapy areas benefit from MSD’s innovative medicines. He is proud to lead a team dedicated to delivering meaningful health solutions that make a lasting difference in people’s lives – from MSD Ireland to the world.